American Society for Radiation Oncology (ASTRO) published its first clinical practice guideline on radiation therapy for ...

Infertility and reproductive health conditions such as endometriosis, polycystic ovary syndrome, progesterone deficiency, insulin resistance, thyroid disease, and male-factor infertility affect ...

The FDA is reviewing durvalumab with enfortumab vedotin for patients with muscle-invasive bladder cancer who cannot receive ...

Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer ...

PADCEV™ (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanced bladder cancer – ...

A retrospective cohort of 186 patients with seromucinous borderline ovarian tumors found that cystectomy and unilateral ...

A Saudi oncologist says bladder-sparing treatment is possible for some muscle-invasive cancer patients, combining surgery, ...

August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...

NHS Fife performs its first robot-assisted bladder cancer operation, a complex radical cystectomy, offering patients advanced care and faster recovery.

AstraZeneca stock closed at GBX 12,552.00 on the London Stock Exchange on September 25, 2026, up 1.23 percent from the ...

US FDA accepts and grants priority review status to AstraZeneca’s sBLA for Imfinzi plus neoadjuvant enfortumab vedotin to treat patients with muscle-invasive bladder cancer: Cam ...